|
|
Información sobre |
|
|
CJ Corp. |
| Tipo de compañía: Productor químico a granel |
| CJ Corp. launched its pharmaceutical business beginning of 1980 by developing Hepatitis B vaccine. In 1990, CJ broke into a new field by completing development of 7-ACA, an intermediate for synthesizing oral and injectable cephalosporins. Since then the company has grown into a global-class producer of synthetic and fermentation based cephalosporin antibiotics. Currently the company expanded its business of biotech products, such as recombinant Erythropoietin, G-CSF and Interferon- alfa, beta to provide innovation and inspiration. CJ is becoming more important major partner and frontier for fine-chemicals and biopharmaceuticals vendors. |
|
| Dirección |
CJ Corp.
500, 5-Ga, Namdaemun-Ro, Chung-Ku
Seoul, 100-802, South Korea
|
| Telefono |
+82 2 726 8342 |
| Fax |
+82 2 6740 1023 |
| Homepage |
www.cj.net |
|
|
|
|
|
|
